🧠 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Calliditas Therapeutics (CALT)

NASDAQ
Currency in USD
Disclaimer
39.80
+0.02(+0.05%)
Closed
After Hours
38.60-1.20(-3.02%)
CALT Scorecard
Full Analysis
Impressive gross profit margins
Fair Value
Day's Range
39.8040.28
52 wk Range
15.2542.10
Prev. Close
39.8
Open
39.81
Day's Range
39.8-40.28
52 wk Range
15.25-42.1
Volume
3,388
Average Volume (3m)
9,370
1-Year Change
145.98%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
CALT Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
227.50
Upside
+9.59%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility
Show more

Calliditas Therapeutics Company Profile

Calliditas Therapeutics AB (publ), a commercial-stage bio-pharmaceutical company, focused on identifying, developing, and commercializing novel treatments in orphan indications with an initial focus on renal and hepatic diseases with significant unmet medical needs in the United States, Europe, and Asia. It offers Nefecon (TARPEYO/Kinpeygo), an oral formulation of budesonide to reduce the loss of kidney function in adults with immunoglobulin A nephropathy. The company’s lead compound is Setanaxib, a NOX inhibitor that is in Phase 2b clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for solid tumors and Alport Syndrome. Calliditas Therapeutics AB (publ) was incorporated in 2004 and is headquartered in Stockholm, Sweden.

Employees
217
Market
Sweden

Compare CALT to Peers and Sector

Metrics to compare
CALT
Peers
Sector
Relationship
P/E Ratio
−23.4x−5.6x−0.6x
PEG Ratio
0.37−0.120.00
Price/Book
105.0x4.8x2.6x
Price / LTM Sales
7.0x17.0x3.1x
Upside (Analyst Target)
−2.0%40.8%56.1%
Fair Value Upside
Unlock−7.3%7.8%Unlock

FAQ

What Is the Calliditas Therapeutics (CALT) Stock Price Today?

The Calliditas Therapeutics stock price today is 39.80

What Stock Exchange Does Calliditas Therapeutics Trade On?

Calliditas Therapeutics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Calliditas Therapeutics?

The stock symbol for Calliditas Therapeutics is "CALT."

What Is the Calliditas Therapeutics Market Cap?

As of today, Calliditas Therapeutics market cap is 1.08B.

What is Calliditas Therapeutics Earnings Per Share?

The Calliditas Therapeutics EPS is -8.95.

What Is the Next Calliditas Therapeutics Earnings Date?

Calliditas Therapeutics will release its next earnings report on Nov 11, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.